{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-019487","form_type":"8-K","ticker":"BCPC","cik":"0000009326","company_name":"BALCHEM CORP","filed_at":"2025-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.872542+00:00","generated_at":"2026-05-23T07:48:13.534122+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Balchem Q1 net sales $250.5M record; adj. EPS $1.22 vs $1.03 YoY; all segments grow","bullets":["Net sales of $250.5M, up 4.5% YoY; GAAP EPS $1.13 vs $0.89; adjusted EPS $1.22 vs $1.03.","Record adjusted EBITDA of $66.3M, up 8.9% YoY; net earnings $37.1M, up 27.8%.","All three segments (Human Nutrition, Animal Nutrition, Specialty Products) posted sales and earnings growth.","Operating cash flow $36.5M; free cash flow $31.0M in Q1 2025.","Launched new corporate website and product brand sites; released 2024 Sustainability Report on April 22."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-019487","json":"https://secwatch.observer/filing/0001628280-25-019487.json","markdown":"https://secwatch.observer/filing/0001628280-25-019487.md","text":"https://secwatch.observer/filing/0001628280-25-019487.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/9326/000162828025019487/0001628280-25-019487-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/9326/000162828025019487/bcpc-20250424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-23T07:48:13.534122+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}